Takeda to reduce European workforce by 2,100

In the wake of its acquisition of Nycomed A/S, and in order to increase productivity, Takeda Pharmaceutical Company Ltd is to embark on a five-year restructuring that will result in job losses of 2,800 globally, of which 2,100 will be in Europe.